Thomas B. Neff, Chief Executive Officer at FIBROGEN INC (FGEN), sold 48,180 shares at $55.94 ($2.7M) on 2019-02-07, disclosed to the SEC on 2019-02-08.
Seasonal sale ($2.7M) by Chief Executive Officer — this insider has traded FGEN in February in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $55.94 | 19,015 | $1.1M | 39.1% |
| 2 | $55.98 | 3,847 | $215K | 7.9% |
| 3 | $57.01 | 487 | $28K | 1.0% |
| 4 | $57.06 | 5,013 | $286K | 10.5% |
| 5 | $56.54 | 5,257 | $297K | 10.9% |
| 6 | $56.79 | 818 |
| $46K |
| 1.7% |
| 7 | $57.05 | 13,593 | $775K | 28.5% |
| 8 | $57.68 | 100 | $6K | 0.2% |
| 9 | $57.68 | 50 | $3K | 0.1% |
| Total | $56.47 avg | 48,180 | $2.7M | 100% |
| Filing → |
| FGEN | SELL | 2019-07-26 | $1.9M | — | Filing → |
| FGEN | SELL | 2019-07-12 | $1.8M | — | Filing → |
| FGEN | SELL | 2019-06-21 | $1.8M | — | Filing → |